13 January 2016 - The SMC has announced forthcoming submissions for the following medicines: brivaracetum (Briviact), cabazitaxel (Jevtana), crizotinib (Xalkori), febuxostat (Adenuric) and secukinumab (Cosentyx).

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions?iru=2ICSSBDQBC